At 13.7x earnings and just 10.6x forward earnings, the market is pricing DAVE like a low-growth cyclical, not a company delivering 18.80% ROE and a massive 55.50% operating margin. A PEG Forward of 0.2 is extreme relative to a forward EPS of $14.65 versus current EPS of 13.2, implying the market is materially discounting its growth durability. The Altman Z-Score of 14.3 signals negligible bankruptcy risk, while a 3.8 current ratio reinforces strong liquidity. This combination of balance sheet safety and discounted forward multiple suggests a probable mispricing in favor of buyers, assuming earnings estimates hold.